Transmitting information to us by e-mail unilaterally does not establish an attorney-client relationship or impose an obligation on either the law firm or even the receiving lawyer to keep the transmitted information confidential. By clicking "OK", you acknowledge that we have no obligation to maintain the confidentiality of any information you submit to us unless we already represent you or unless we have agreed to receive limited confidential material/information from you as a prospective client. Thus, if you are not a client or someone we have agreed to consider as a prospective client, information you submit to us by e-mail may be disclosed to others or used against you. If you would like to discuss becoming a client, please contact one of our attorneys to arrange for a meeting or telephone conference. If you wish to disclose confidential information to a lawyer in the firm before an attorney-client relationship is established, the protections that the law firm will provide to such information from a prospective client should be discussed before such information is submitted. Thank you for your interest in Goodwin Procter.

COVID-19 Insolvency Risks: Guidance for UK Directors

main

11_30_20 SBLDTLGuidanceToDirectors

11_30 COVID 19 Insolvency Risks Guidance

Stay informed with our article: COVID-19 Insolvency Risks: Guidance for UK Directors and what this means for you.

COVID-19 Insolvency Risks: Guidance for UK Directors

Contacts

Simon Thomas

Related Content

A Brief Defense of COMI

Complicit Defendants Lose, Sovereign Agency Wins in Eternal Madoff Litigation

FDIC Proposes Guidelines for Corporate Governance and Risk Management

Delaware ABCs (Assignments for the Benefit of Creditors): No Longer as Easy as 1-2-3

Second Circuit Rules that Syndicated Loans Are Not “Securities” Under State and Federal Law

A Vital Decision on Social Media Ownership

The Silicon Valley Bank UK insolvency: FAQ for those doing business with the Bank

New Decision on Lease Rejection Damages

Abingworth to Provide Teva with up to $150 Million in Financing to Advance Treatment of Asthma

Goodwin Represents Loparex in Uptier Exchange Liability Management Transaction

The Legal 500 EMEA 2024 Recognizes Goodwin for Excellence Across Europe

VALCON 2024

A Glimpse into the Future: AI, the Metaverse and the Insolvency Profession

Shanghai Argo Announces Multi-Program RNAi Licenses and Strategic Collaborations with Novartis

Goodwin Names 15 New Counsel

TPI Composites, Inc. Announces Refinancing Transaction with Oaktree

Financial Restructuring